China Advances Digital and Intelligent Transformation of Pharmaceutical Industry

On April 24, 2025, the Notice of the Ministry of Industry and Information Technology (MIIT) and Six Other Departments on Issuing the Implementation Plan for the Digital-Intelligent Transformation of the Pharmaceutical Industry (2025–2030) (the “Plan”) was released on MIIT’s official website, which took effect on the same day.

The Plan states that by 2027, significant progress will be made in the digital and intelligent transformation of the pharmaceutical industry, with over 100 typical scenarios for the application of digital and intelligent technologies in the industry created; by 2030, enterprises above a designated size in the pharmaceutical industry will have basically achieved full coverage of digital and intelligent transformation.

The Plan deploys four key actions: empowerment through digital and intelligent technologies, promotion of digital and intelligent transformation, construction of digital and intelligent service systems, and enhancement of digital and intelligent regulation, while specifying detailed work requirements. For safeguards, the Plan calls for strengthened policy support to advance the research, development, and promotion and application of digital and intelligent technologies and products in the pharmaceutical industry. Local governments are encouraged to coordinate support policies related to projects, financing, land use, and energy consumption to facilitate the early implementation of key digital and intelligent transformation projects by pharmaceutical enterprises. Financial institutions are guided to provide medium- and long-term loans, supply chain finance, financial leasing, listing guidance, and other financial services for digital and intelligent transformation projects in the pharmaceutical industry.